West Pharmaceutical Services (WST) Finished Goods (2010 - 2012)

West Pharmaceutical Services (WST) has reported Finished Goods for 3 consecutive years, with $65.3 million the latest figure, recorded in Q2 2012.

• Quarterly Finished Goods fell 9.18% year-over-year to $65.3 million in Q2 2012, while the trailing twelve-month figure through Jun 2012 was $65.3 million (down 9.18% YoY) and the FY2011 annual result came in at $67.1 million, up 3.07% from the prior year.
• Finished Goods retreated to $65.3 million in Q2 2012 per WST's latest filing, from $67.1 million in the prior quarter.
• Over the last five years, Finished Goods for WST reached as high as $71.9 million in Q2 2011 and fell as low as $65.1 million in Q4 2010.
• A 3-year average of $67.7 million and a median of $67.1 million in 2011 frame the typical range for Finished Goods.
• Annual changes were most pronounced in 2011 — Finished Goods climbed 3.07% — and 2012, when it declined 9.18%.
• Year by year, Finished Goods stood at $65.1 million in 2010, then advanced by 3.07% to $67.1 million in 2011, then retreated by 2.68% to $65.3 million in 2012.
• According to Business Quant data, Finished Goods over the past three periods registered $65.3 million, $67.1 million, and $68.9 million for Q2 2012, Q4 2011, and Q3 2011 respectively.